These are promising results, but the studys authors note that more research is needed, and clinicians must also consider potential adverse effects, evaluate the cost-effectiveness of these medications for each patient, and closely monitor for any improvement or worsening of eating disorders and related side effects. That hesitation is shared by the National Eating Disorder Association (NEDA), who published an opinion paper on GLP-1s and eating disorders in 2024, stating: While there is some evidence that GLP-1s can decrease the number of binge eating episodes for those with BED, little is known about the long term physical and psychological impact on those with eating disorders. How GLP-1s could also fuel eating disorders The same mechanisms that make these medications helpful for some could make them harmful for others
Maca c tc dng ph khng
The risk increases if you also take insulin or a sulfonylurea (such as glipizide), because those drugs can work together in ways that drop your blood sugar too much
In the UK, the estimated spend on obesity in 2014/15 was 6.1 billion and is projected to reach 9.7 billion by 2050, with an estimated societal cost of almost 50 billion [5]
For Youths Solution: Try The Protect Glutathione+ , formulated to enhance antioxidant defense and reduce cellular damage